State Street
TNGX icon

State Street’s Tango Therapeutics TNGX Stock Holding History

State Street’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97.3M Sell
4,651,894
-1,566,673
-25% -$21.8M ﹤0.01% 1387
2025
Q4 		$55.1M Buy
6,218,567
+2,853,362
+85% +$24.6M ﹤0.01% 1685
2025
Q3 		$28.3M Buy
3,365,205
+1,982,519
+143% +$13.4M ﹤0.01% 2051
2025
Q2 		$7.08M Buy
1,382,686
+238,243
+21% +$589K ﹤0.01% 2791
2025
Q1 		$1.57M Sell
1,144,443
-86,756
-7% -$213K ﹤0.01% 3324
2024
Q4 		$3.8M Sell
1,231,199
-1,087,009
-47% -$5.05M ﹤0.01% 3073
2024
Q3 		$17.9M Buy
2,318,208
+489,949
+27% +$4.68M ﹤0.01% 2274
2024
Q2 		$15.7M Sell
1,828,259
-1,037,839
-36% -$8.02M ﹤0.01% 2294
2024
Q1 		$22.8M Buy
2,866,098
+1,887,160
+193% +$20.2M ﹤0.01% 2137
2023
Q4 		$9.69M Buy
978,938
+25,059
+3% +$218K ﹤0.01% 2613
2023
Q3 		$10.7M Buy
953,879
+54,940
+6% +$335K ﹤0.01% 2554
2023
Q2 		$2.98M Buy
898,939
+77,410
+9% +$278K ﹤0.01% 3231
2023
Q1 		$3.25M Sell
821,529
-22,340
-3% -$130K ﹤0.01% 3149
2022
Q4 		$6.12M Sell
843,869
-28,733
-3% -$202K ﹤0.01% 2956
2022
Q3 		$3.16M Buy
872,602
+130,266
+18% +$556K ﹤0.01% 3273
2022
Q2 		$3.36M Buy
742,336
+495,202
+200% +$3M ﹤0.01% 3293
2022
Q1 		$1.87M Buy
247,134
+17,141
+7% +$149K ﹤0.01% 3594
2021
Q4 		$2.52M Buy
229,993
+31,893
+16% +$384K ﹤0.01% 3573
2021
Q3 		$2.56M Buy
+198,100
New +$2.37M ﹤0.01% 3542

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

State Street's TNGX Position: Q1 2026 in Review

State Street reduced its Tango Therapeutics (TNGX) stake by 25% in Q1 2026, selling an estimated $21.8M and leaving 4,651,894 shares worth $97.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

State Street first reported a position in TNGX in Q3 2021 and has held it in 19 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • State Street held 4,651,894 shares of Tango Therapeutics worth $97.3M as of Q1 2026.
  • State Street sold 1,566,673 Tango Therapeutics shares in Q1 2026, an estimated $21.8M.
  • Tango Therapeutics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #1387 holding.
  • State Street first reported a position in Tango Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.